How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,461 results for

Failure to Thrive

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Failure to thrive

Failure to thrive Failure to thrive - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Failure to thrive Last reviewed: February 2019 Last updated: January 2018 Summary The diagnosis of failure to thrive (FTT) requires a careful assessment of growth parameters (weight, length/height, and head circumference) over time. The condition requires a comprehensive evaluation as both medical and psychosocial problems may (...) ://www.ncbi.nlm.nih.gov/pubmed/12043359?tool=bestpractice.com However, the definition varies between different healthcare providers, and the criteria used to diagnose the condition must be specified. FTT can be a pejorative term. Under-nutrition is a descriptive term for poor growth and is preferred because it is more specific than FTT; it does not compound the possible failure parents may feel due to their infant's poor growth. Kessler DB. Failure to thrive and pediatric undernutrition: historical and theoretical

2018 BMJ Best Practice

3. Novel DSP Spectrin 6 Region Variant Causes Neonatal Erythroderma, Failure to Thrive, Severe Herpes Simplex Infections and Brain Lesions. (PubMed)

Novel DSP Spectrin 6 Region Variant Causes Neonatal Erythroderma, Failure to Thrive, Severe Herpes Simplex Infections and Brain Lesions. Desmoplakin (DSP) and Desmoglein 1 (DSG1) variants result in skin barrier defects leading to erythroderma, palmoplantar keratoderma and variable [AQ4] other features. Some DSG1 variant carriers present with SAM syndrome (Severe dermatitis, multiple Allergies, Metabolic wasting) and a SAM-like phenotype has been reported in 4 subjects with different

Full Text available with Trip Pro

2019 Acta Dermato-Venereologica

4. Heterozygous RNF13 Gain-of-Function Variants Are Associated with Congenital Microcephaly, Epileptic Encephalopathy, Blindness, and Failure to Thrive. (PubMed)

Heterozygous RNF13 Gain-of-Function Variants Are Associated with Congenital Microcephaly, Epileptic Encephalopathy, Blindness, and Failure to Thrive. Accumulation of unfolded proteins in the endoplasmic reticulum (ER) initiates a stress response mechanism to clear out the unfolded proteins by either facilitating their re-folding or inducing their degradation. When this fails, an apoptotic cascade is initiated so that the affected cell is eliminated. IRE1α is a critical sensor of the unfolded

2018 American Journal of Human Genetics

5. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study

The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study (THRIVE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03524534 Recruitment Status : Completed First Posted : May 15, 2018 Last Update Posted : January 9, 2019 Sponsor: Kaiser Permanente Collaborator

2018 Clinical Trials

6. Failure to Thrive among Immigrant and Refugee Children: A Quality Improvement Project to Innovate a Primary Care Approach. (PubMed)

Failure to Thrive among Immigrant and Refugee Children: A Quality Improvement Project to Innovate a Primary Care Approach. This quality improvement (QI) project aimed to improve primary care for immigrant and refugee children with failure to thrive (FTT) in a diverse clinic where elevated rates of FTT were noted.The QI intervention included a patient registry managed by a care coordinator, a manual to educate providers, and group visits for patients with shared primary language. Rates

2018 Journal of health care for the poor and underserved

7. Cricopharyngeal achalasia associated with laryngomalacia as a cause of failure to thrive. (PubMed)

Cricopharyngeal achalasia associated with laryngomalacia as a cause of failure to thrive. To describe a case of concurrent cricopharyngeal achalasia with laryngomalacia as a cause of failure to thrive, and to review the literature and management options of cricopharyngeal achalasia in the paediatric population.A chart review was performed on a four-month-old male, referred for failure to thrive, and diagnosed with cricopharyngeal achalasia and laryngomalacia. A PubMed and Embase search (...) and resolution of failure to thrive. The literature review revealed no reported case of the combined pathologies as a cause of failure to thrive.Functional endoscopic evaluation of swallowing and videofluoroscopic evaluation of swallowing are complimentary in the evaluation of paediatric patients with failure to thrive and suspected oropharyngeal dysphagia. Both supraglottoplasty and botulinum toxin injection are effective for definitive management in cases of combined pathology, and can be safely performed

2018 Journal of Laryngology & Otology

8. Ruptured Thoracic and Abdominal Gastrointestinal Duplication Cysts Presenting With Failure to Thrive. (PubMed)

Ruptured Thoracic and Abdominal Gastrointestinal Duplication Cysts Presenting With Failure to Thrive. Gastrointestinal duplication cysts are rare congenital malformations, with esophageal and gastric duplication cysts being among the rarest. We report an 8-week-old female who presented to the emergency department with failure to thrive and was subsequently found to have multiple gastric and esophageal duplication cysts that had ruptured intrathoracically and intra-abdominally. We describe

2018 Pediatric Emergency Care

9. A 3-Month-Old With Failure to Thrive and Persistent Vomiting. (PubMed)

A 3-Month-Old With Failure to Thrive and Persistent Vomiting. A 3-month-old boy was admitted from his pediatrician's office for failure to thrive and vomiting. On admission, he weighed barely more than his birth weight and was cachectic with muscle wasting. His abdomen was grossly distended but soft and nontender. A trial of nasogastric feeds resulted in a worsening of his clinical status. He was transferred to the ICU, and diagnostic imaging was concerning for a distal bowel obstruction

Full Text available with Trip Pro

2017 Pediatrics

10. Effects of zinc supplementation on catch-up growth in children with failure to thrive (PubMed)

Effects of zinc supplementation on catch-up growth in children with failure to thrive Although globally the numbers of children diagnosed with failure to thrive (FTT) have decreased, FTT is still a serious pediatric problem. We aimed to investigate the effects of zinc supplementation for 6 months on growth parameters of infants and children with FTT.In this retrospective study, of the 114 participants aged between 4 months and 6 years, 89 were included in the zinc supplementation group and were

Full Text available with Trip Pro

2017 Nutrition research and practice

11. Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive (PubMed)

Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive 29248509 2018 11 13 2352-3964 27 2018 Jan EBioMedicine EBioMedicine Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive. 5-6 S2352-3964(17)30487-5 10.1016/j.ebiom.2017.12.006 Leoni C C Center for Rare Diseases and Birth Defects, Institute of Pediatrics, Department of Woman And Child Health, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic (...) address: chiara.leoni@policlinicogemelli.it. Flex E E Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. eng Journal Article 2017 12 07 Netherlands EBioMedicine 101647039 2352-3964 Costello Syndrome Failure to thrive Hypoglycemia 2017 11 22 2017 12 06 2017 12 19 6 0 2017 12 19 6 0 2017 12 18 6 0 ppublish 29248509 S2352-3964(17)30487-5 10.1016/j.ebiom.2017.12.006 PMC5828550 Sci Rep. 2017 Apr 28;7(1):1256 28455524 Am J Med Genet A. 2005 Dec 15;139(3):227-30

Full Text available with Trip Pro

2017 EBioMedicine

12. Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data (PubMed)

Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data 29150053 2018 07 17 2018 11 13 1873-2518 35 48 Pt A 2017 12 04 Vaccine Vaccine Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. 6483-6491 S0264-410X(17)30116-0 10.1016/j.vaccine.2017.01.051 Ross Elizabeth E Monash University, Department of Paediatrics, Monash Children's Hospital (...) and Immunity, Monash Children's Hospital, Monash Health; SAEFVIC, Murdoch Children's Research Institute, Melbourne, Australia. Electronic address: contact@brightoncollaboration.org. Brighton Collaboration Failure to Thrive Working Group eng Guideline Journal Article Netherlands Vaccine 8406899 0264-410X IM Adverse Drug Reaction Reporting Systems standards Child, Preschool Data Collection standards Epidemiologic Methods Failure to Thrive epidemiology Humans Infant Infant, Newborn Vaccination adverse effects

Full Text available with Trip Pro

2017 Vaccine

13. Helicobacter pylori infection is not associated with failure to thrive: a case control study (PubMed)

Helicobacter pylori infection is not associated with failure to thrive: a case control study The long-term impact of Helicobacter pylori infection is complex, and concerns about the need for eradication exist. We conducted this case control study to investigate the association between H. pylori infection and failure to thrive (FTT).From January 2009 to December 2011, 53 children with FTT group and matched children with the same sex and age and similar socioeconomic status without FTT (control

Full Text available with Trip Pro

2017 Therapeutics and clinical risk management

14. A unique association of Noonan syndrome and 47,XYY syndrome in a male presenting with failure to thrive (PubMed)

A unique association of Noonan syndrome and 47,XYY syndrome in a male presenting with failure to thrive We describe a 24-month-old male patient who presented to our Genetics-Endocrinology Clinic with a history of failure to thrive, short stature and cryptorchidism. Soon after birth he was diagnosed with 47,XYY syndrome, but due unusual facial features had further diagnostic workup which revealed Noonan syndrome (NS) as well. This report illustrates significant phenotypic-cytogenetic variability

Full Text available with Trip Pro

2017 Oxford Medical Case Reports

15. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death (PubMed)

Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death Eukaryotic elongation factor 1A (EEF1A), is encoded by two distinct isoforms, EEF1A1 and EEF1A2; whereas EEF1A1 is expressed almost ubiquitously, EEF1A2 expression is limited such that it is only detectable in skeletal muscle, heart, brain and spinal cord. Currently, the role of EEF1A2 in normal cardiac development and function is unclear. There have been several (...) reports linking de novo dominant EEF1A2 mutations to neurological issues in humans. We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood. A third sibling also died of a similar presentation, but DNA was unavailable to confirm the mutation. Functional genomic analysis was performed in S. cerevisiae and zebrafish. In S

Full Text available with Trip Pro

2017 Human molecular genetics

16. Retroperitoneal Mass Masquerading as Failure to Thrive in a 91-year-old Woman (PubMed)

Retroperitoneal Mass Masquerading as Failure to Thrive in a 91-year-old Woman Failure to thrive (FTT) is a state of overall decline. Patients often present with weight loss, poor appetite, malnutrition, and decreased physical functioning. The etiology is multifactorial including chronic diseases, functional impairments, and acute illnesses. Evaluation for reversible causes is paramount, and treatment is aimed at maintaining or improving functional status. We present a case of a 91-year-old (...) woman with a retroperitoneal mass that was found on workup for failure to thrive.

Full Text available with Trip Pro

2017 Cureus

17. Parent-Infant Interaction for Non-Organic Failure to Thrive

Parent-Infant Interaction for Non-Organic Failure to Thrive Copyright © 2011 Cincinnati Children's Hospital Medical Center; all rights reserved. Page 1 of 7 Patient Services/Non-Organic Failure to Thrive/Parent-infant Interaction / BESt 099 Best Evidence Statement (BESt) Date: June 28, 2011 Parent-Infant Interaction and Non-Organic Failure to Thrive Topic and/or question as originally asked How do parent-child interactions in the context of feeding support or inhibit child acceptance of oral (...) intake? Is there a way to reliably evaluate parent-child interactions during feeding and provide strategies for improving interaction that may facilitate improved growth? Clinical Question P (population/problem) Among formula-fed infants admitted for inpatient hospitalization with non- organic failure to thrive and their primary caregivers I (intervention) does focused parent-child interaction education in addition to standard care C (comparison) compared with standard care O(outcome) improve weight

2011 Cincinnati Children's Hospital Medical Center

18. Developmental delay and failure to thrive in a 7-month-old baby boy with spontaneous transient Graves’ thyrotoxicosis: a case report (PubMed)

Developmental delay and failure to thrive in a 7-month-old baby boy with spontaneous transient Graves’ thyrotoxicosis: a case report Thyroid dysfunction can induce developmental delay and failure to thrive in infancy. Congenital hypothyroidism is one of the common causes of these symptoms in infancy. By contrast, hyperthyroidism is a rare cause of these symptoms in infancy.A 7-month-old Japanese baby boy was examined for developmental delay and failure to thrive. Blood tests were performed (...) of developmental delay and fail to thrive.

Full Text available with Trip Pro

2016 Journal of medical case reports

19. The Effects of a High-fiber Formula in Children With Failure to Thrive

The Effects of a High-fiber Formula in Children With Failure to Thrive The Effects of a High-fiber Formula in Children With Failure to Thrive - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Effects (...) of a High-fiber Formula in Children With Failure to Thrive The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02819401 Recruitment Status : Completed First Posted : June 30, 2016 Last Update Posted : June 30, 2016 Sponsor: Abbott Nutrition Information provided by (Responsible Party): Abbott Nutrition Study

2016 Clinical Trials

20. Investigating Transitional Care to Decrease Post-pancreatectomy 30-Day Hospital Readmissions for Dehydration or Failure to Thrive. (PubMed)

Investigating Transitional Care to Decrease Post-pancreatectomy 30-Day Hospital Readmissions for Dehydration or Failure to Thrive. Current literature emphasizes post-operative complications as a leading cause of post-pancreatectomy readmissions. Transitional care factors associated with potentially preventable conditions such as dehydration and failure to thrive (FTT) may play a significant role in readmission after pancreatectomy and have not been studied.Thirty-one post-pancreatectomy (...) ), the absence of family during the delivery of discharge instructions (P = 0.0098), episodic intermittent nausea at discharge (P = 0.0019), uncertainty about quantity, quality, or frequency of fluid intake (P = 0.0137), and the inability or failure to adhere to the clinician's instructions in the outpatient setting (P = 0.0048).Transitional-care-related factors are found to be associated with post-pancreatectomy readmission for dehydration and FTT. Using these results to identify high-risk patients

2016 Journal of Gastrointestinal Surgery

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>